Front Row Advisors’s Chemed CHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-9
Closed -$4.88K 569
2024
Q2
$4.88K Hold
9
﹤0.01% 732
2024
Q1
$5.78K Buy
+9
New +$5.47K ﹤0.01% 703
2023
Q4
Sell
-9
Closed -$4.68K 541
2023
Q3
$4.68K Hold
9
﹤0.01% 686
2023
Q2
$5K Hold
9
﹤0.01% 657
2023
Q1
$5K Hold
9
﹤0.01% 658
2022
Q4
$5K Hold
9
﹤0.01% 628
2022
Q3
$4K Hold
9
﹤0.01% 682
2022
Q2
$4K Hold
9
﹤0.01% 706
2022
Q1
$5K Hold
9
﹤0.01% 711
2021
Q4
$5K Sell
9
-4
-31% -$1.92K ﹤0.01% 734
2021
Q3
$6K Hold
13
﹤0.01% 689
2021
Q2
$6K Hold
13
﹤0.01% 684
2021
Q1
$6K Sell
13
-5
-28% -$2.45K ﹤0.01% 667
2020
Q4
$10K Hold
18
0.01% 514
2020
Q3
$9K Hold
18
﹤0.01% 526
2020
Q2
$8K Hold
18
0.01% 514
2020
Q1
$7K Buy
18
+9
+100% +$4.02K ﹤0.01% 536
2019
Q4
$4K Hold
9
﹤0.01% 655
2019
Q3
$4K Hold
9
﹤0.01% 642
2019
Q2
$3K Hold
9
﹤0.01% 712
2019
Q1
$3K Hold
9
﹤0.01% 709
2018
Q4
$3K Hold
9
﹤0.01% 657
2018
Q3
$3K Hold
9
﹤0.01% 672
2018
Q2
$3K Sell
9
-14
-61% -$4.38K ﹤0.01% 733
2018
Q1
$6K Hold
23
﹤0.01% 523
2017
Q4
$6K Buy
+23
New +$5.22K ﹤0.01% 504

Other funds holding CHE

Front Row Advisors's CHE Position: Q3 2024 in Review

Front Row Advisors sold out of Chemed (CHE) in Q3 2024, closing a stake of 9 shares — an estimated $4.88K sold.

Front Row Advisors first reported a position in CHE in Q4 2017 and held it in 26 quarters. The position peaked at $10K in Q4 2020. 528 funds tracked by Wall St. Rank hold CHE as of Q3 2024.

  • Front Row Advisors reported no remaining Chemed position as of Q3 2024 after selling out during the quarter.
  • Front Row Advisors sold 9 Chemed shares in Q3 2024, an estimated $4.88K.
  • Front Row Advisors first reported a position in Chemed in Q4 2017 and held it in 26 quarters.
  • Front Row Advisors's Chemed position peaked at $10K in Q4 2020.
  • 528 funds tracked by Wall St. Rank held Chemed as of Q3 2024.

Based on Front Row Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.